date:Sep 14, 2012
and CEO, Stempeutics Research Pvt. Ltd.; Virender S Sangwan, associate director, L V Prasad Eye Institute (LVPEI), and Chandra Viswanathan, head of regenerative medicines group, Reliance Life Sciences were the panellists. A keynote and plenary luncheon on 'Strategies for Success: India's Global Role in Innovation' also took place the same day. Achin Gupta, director, strategic planning, Abbott Laboratories; Phil Kearney, director, external scientific affairs, worldwide licensing, Merck; Chaitanya